Editas Medicine, Inc.EDITNASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-219.11M
↓ 106% below average
Average (9y)
$-106.53M
Historical baseline
Range
High:$-6.83M
Low:$-219.11M
CAGR
+47.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-219.11M | -60.1% |
| 2023 | $-136.90M | +24.6% |
| 2022 | $-181.47M | -5.6% |
| 2021 | $-171.78M | +8.1% |
| 2020 | $-187.00M | -299.3% |
| 2019 | $-46.84M | +7.2% |
| 2018 | $-50.46M | -339.7% |
| 2017 | $-11.48M | +78.5% |
| 2016 | $-53.42M | -681.7% |
| 2015 | $-6.83M | - |